| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7115ef17a0cce55f36229865e31ea6a0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 |
| filingDate |
1994-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc6a639446db1954f32d77dc0f0bf359
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99b780e12b6f7a94da240c2f769f88db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bfe4bece9957282881021fb25c87101
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdb051896ec463f6144d4a19906f3294 |
| publicationDate |
1995-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9505176-A1 |
| titleOfInvention |
Use of ergoline derivatives for the treatment of glaucoma |
| abstract |
The use of certain dopaminergic compounds for controlling elevations of intraocular pressure is disclosed. The compounds are ergoline derivatives. The most preferred compound is cabergoline. The compounds have been found to produce a significant reduction of intraocular pressure. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6107414-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7939665-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03074054-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6953854-B2 |
| priorityDate |
1993-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |